TCEA3 and non-small cell lung carcinoma: Studies have shown that tRF‐Leu‐CAG promotes NSCLC tumour growth and metastasis by targeting TCEA3 and enhances paclitaxel resistance by augmenting cellular autophagy, providing potential effective targets and therapeutic options for clinical NSCLC treatment.255